The Triana Group is pleased to announce Jabril Bensedrine’s appointment on Nextep’s Advisory Board.
Founded in 1999 in Paris, Nextep has grown into a life sciences strategy consulting firm with clients including most of the world’s largest pharmaceutical companies. Its services range from market access, pricing and regulatory affairs, to partnerships and business development.
Bringing to Nextep’s advisory board his strategy background and US market perspective, Jabril Bensedrine joins Dr. Jean-Jacques Zambrowski (Hospital Bichat; Descartes University in Paris); Dr. Golriz Pahlavan (clinical specialist of AIDS and infectious diseases, member of the Medical Consultative Committee of the Hospital Bichat); Olivier Safir (Pact & Partners, one of the world’s leading life sciences Executive Recruiting Firms); Dr. Laurent Bourgeon (Associate Professor, ESSEC Paris-Singapore; Visiting Scholar at the Australian Graduate School of Management, Sydney and SCOR, Stanford University); Dominique Dupont (owner, founder, president of renowned publishing houses Droit et Pharmacie, Editions de Santé, and Industrie Santé; President of Club Européen de la Sante and host of the prestigious invitation-only Cercle Industrie Santé); Pharma Dr. Philippe Girault (Recherche Innovation Santé Education; previously Director at Hoechst, at Roche, at Amgen, and at Celgene).
Nextep was founded by Guillaume Bouchara, formerly in charge of Health Economics at Pfizer. Along with the President of Pfizer, he is the co-founder of the French-based Association of American Research Laboratories.
Nextep appoints The Triana Group’s Jabril Bensedrine on its Board of Advisors
